Cipla USA, Inc.: 23 recalls on record

Recalls filed with 1 agency: FDA (23).

First recall on record: July 19, 2023. Most recent: July 8, 2026.

Risk classification: Class I: 1 · Class II: 18 · Class III: 4

Most recent recalls

DateAgencyProduct
July 8, 2026FDACinacalcet Hydrochloride Tablets, 60 mg, 30-count bottle, Rx Only, Manufactured by: Cipla…D-0675-2026
July 8, 2026FDACinacalcet Hydrochloride Tablets, 90 mg, 30-count bottle, Rx Only, Manufactured by: Cipla…D-0676-2026
July 8, 2026FDACinacalcet Hydrochloride Tablets, 30 mg, 30-count bottle, Rx Only, Manufactured by: Cipla…D-0661-2026
April 22, 2026FDACinacalcet Hydrochloride Tablets, 60 mg, 30 Tablets per bottle, Rx Only, Manufactured by:…D-0450-2026
April 22, 2026FDACinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured by:…D-0449-2026
April 22, 2026FDACinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by:…D-0451-2026
April 15, 2026FDALanreotide Injection, 120 mg/0.5 mL, Box contains 1 Pre-filled syringe, Single dose only,…D-0423-2026
April 15, 2026FDALanreotide Injection, 120 mg*/0.5 mL, Box contains 1 Pre-filled syringe and 1 safety need…D-0422-2026
March 11, 2026FDANilotinib Capsules, 150 mg per capsule, packaged in cartons, Rx only, Manufactured by: Ci…D-0381-2026
March 11, 2026FDANilotinib Capsules, 200 mg per capsule, packaged in cartons, Rx only, Manufactured for: C…D-0382-2026
January 28, 2026FDADiclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laborator…D-0291-2026
January 21, 2026FDALanreotide Injection, 120 mg/0.5 mL, 0.5 mL per pre-filled syringe, For deep subcutaneous…D-0290-2026
December 17, 2025FDACinacalcet Hydrochloride Tablets, 60 mg, 30 Tablets per bottle, Rx Only, Manufactured for…D-0225-2026
December 17, 2025FDALanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx O…D-0217-2026
December 17, 2025FDALanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx O…D-0218-2026
December 17, 2025FDACinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured for…D-0226-2026
December 17, 2025FDACinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured for…D-0224-2026
August 27, 2025FDAAlbuterol Sulfate, Inhalation Aerosol, 90 mcg, 200 metered Inhalations, NET CONTENT 6.7 g…D-0593-2025
July 30, 2025FDABudesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per …D-0541-2025
November 20, 2024FDALanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for …D-0044-2025
November 20, 2024FDALanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for …D-0043-2025
May 1, 2024FDAIpratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-…D-0471-2024
July 19, 2023FDAAlbuterol Sulfate Inhalation Aerosol, 90 mcg, 200 Metered Inhalation, net content 6.7 g c…D-0938-2023

Questions about this company

How many recalls does Cipla USA, Inc. have?
Recalert has 23 U.S. recalls on record for Cipla USA, Inc., published between July 19, 2023 and July 8, 2026.
What was the most recent Cipla USA, Inc. recall?
FDA recall D-0675-2026, published July 8, 2026: Cinacalcet Hydrochloride Tablets, 60 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warre…
Which agencies have handled Cipla USA, Inc. recalls?
Cipla USA, Inc. appears as the recalling firm in recalls from: FDA (23).

Do you carry products from Cipla USA, Inc.? Check your whole catalog free against 80,000+ recalls.

Paste up to 100 UPCs or SKUs and see which ones match a CPSC, FDA, NHTSA or FSIS recall. No account needed.

Check my catalog free

Want it checked every night instead? Starter watches 500 SKUs for $29/month. See plans

Related companies